Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 13, 2010
IR Global Rankings ("IRGR"), the most comprehensive technical ranking system for investor relations websites, corporate governance practices and...
-
Dec 10, 2010
JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 12/10/10 -- www.stockcall.com/ offers investors comprehensive research on the drug related products industry and has completed analytical research on...
-
Nov 29, 2010
In the news release, Perrigo Announces Launch of Naproxen Sodium Soft Gels - Generic Equivalent to Aleve® Liquid Gels, issued 29-Nov-2010 by Perrigo over PR Newswire, we are advised by the...
-
Nov 29, 2010
Perrigo (Nasdaq: PRGO;TASE) today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug...
-
Nov 29, 2010
Perrigo (Nasdaq: PRGO; TASE) today announced that it has launched Naproxen Sodium Soft Gels. The product is the generic equivalent of Bayer...
-
Nov 23, 2010
IR Global Rankings (IRGR) is pleased to announce that it will collaborate with Institutional Investor magazine on a series of Investor Relations events...
-
Nov 10, 2010
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Credit Suisse Annual...
-
Nov 9, 2010
JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 11/09/10 -- www.wallstreetequityresearch.com brings investors market knowledge on the aspects moving the drug related products stocks, and offers...
-
Nov 2, 2010
Fiscal first quarter revenue from continuing operations increased $113 million, or 21 percent, to a record $641 million Fiscal first quarter...
-
Oct 27, 2010
Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.07 per share, payable on...